Press ReleasesAugust 11, 2023BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% AccuracyRead
Media CoverageMay 1, 2023BillionToOne, Inc., Secures Landmark Win in Lawsuit Against CDPH’s PNS Program in Order to Maintain Patient and Provider Choice Regarding Cell-free DNA Screening for Trisomy 21, 18, and 13Read
Press ReleasesJanuary 23, 2023BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial UseRead
Press ReleasesDecember 16, 2022BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility, Demonstrating Investor and Lender Confidence in the Company’s Rapid GrowthRead
Press ReleasesDecember 6, 2022BillionToOne Announces New Clinical Outcomes Data Showing High Sensitivity of UNITY Screen™ to Detect Pregnancies at Risk for Recessive ConditionsRead
Press ReleasesDecember 2, 2022BillionToOne Appoints Tom Lynch, JD, as General Counsel & Chief Compliance OfficerRead